Oncomine Myeloid Panel
Introduction to the Oncomine Myeloid Panel
The Oncomine Myeloid Panel is a sophisticated genetic test designed to detect mutations in genes associated with various myeloid malignancies, including Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Chronic Myelomonocytic Leukemia (CMML), and Juvenile Myelomonocytic Leukemia (JMML). This test is crucial for individuals showing symptoms or having risk factors related to these conditions, as it provides valuable insights for diagnosis and treatment planning.
What the Test Measures
The Oncomine Myeloid Panel measures specific genetic mutations that may indicate the presence of myeloid malignancies. By employing Next-Generation Sequencing (NGS) technology, the test can identify multiple mutations from a single sample, providing a comprehensive view of the genetic landscape associated with these diseases.
Who Should Consider This Test?
Individuals who may benefit from the Oncomine Myeloid Panel include:
- Patients exhibiting symptoms such as fatigue, unexplained bruising, or frequent infections.
- Individuals with a family history of myeloid malignancies.
- Patients who have been diagnosed with a myeloid condition and require further genetic analysis for treatment decisions.
- Those who have undergone previous treatments and are experiencing relapses.
Benefits of Taking the Test
The Oncomine Myeloid Panel offers several benefits, including:
- Accurate identification of genetic mutations that guide treatment selection.
- Enhanced understanding of the disease, which can lead to better management strategies.
- Potential for personalized medicine approaches, improving patient outcomes.
- Facilitation of clinical trials for targeted therapies based on genetic findings.
Understanding Your Results
Results from the Oncomine Myeloid Panel are typically available within 2-3 weeks. It is essential to discuss these results with a healthcare provider, who can interpret the findings and recommend appropriate next steps based on the specific mutations detected.
Test Name and Pricing
| Test Name | Discount Price (KSh) | Regular Price (KSh) |
|---|---|---|
| Oncomine Myeloid Panel | 75,000 | 100,000 |
Sample Collection and Pre-Test Instructions
The Oncomine Myeloid Panel requires a sample of bone marrow or peripheral blood. Samples are collected using:
- Sodium Heparin Vacutainer (2ml)
- EDTA Vacutainer (3ml)
Pre-test instructions include the necessity of a doctor’s prescription for the test, which is not applicable for surgery, pregnancy cases, or individuals planning to travel abroad.
Book Your Test Today!
We have branches across all major cities in Kenya, and we also offer home sample collection services for your convenience. To book the Oncomine Myeloid Panel or for more information, please call or WhatsApp us at +254711564616.
